BURLINGTON, Mass.--(BUSINESS WIRE)--Dyax Corp. (NASDAQ: DYAX) announced today that executive management will participate in the Rodman & Renshaw Annual Global Investment Conference, being held September 10-11, 2012 at The Waldorf Astoria in New York City. Gustav Christensen, President and Chief Executive Officer of Dyax, will present on Monday, September 10 at 12:05 PM (ET). Mr. Christensen will provide a corporate update regarding the Company’s key value drivers – KALBITOR® and the angioedema franchise, as well as the Licensing and Funded Research Program (LFRP).
